Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on Preliminary Safety and Efficacy of the ARC-IM Therapy to Support Hemodynamic Management in People With Typical and Atypical Parkinson's Disease

NCT06920134 is registered in ClinicalTrials.gov with Ecole Polytechnique Fédérale de Lausanne as lead sponsor.

NCT NCT06920134
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06920134 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on Preliminary Safety and Efficacy of the ARC-IM Therapy to Support Hemodynamic Management in People With Typical and Atypical Parkinson's Disease
Lead sponsor
Ecole Polytechnique Fédérale de Lausanne
Phase
Not applicable
Overall status
Recruiting
Start date
July 3, 2025
Completion date
May 1, 2031
Enrollment
5 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypotension symptomatic, multiple system atrophy (msa) with orthostatic hypotension, multiple system atrophy - parkinsonian subtype (msa-p), orthostatic hypotension, dysautonomic, parkinson's disease